Related Experiment Video
Updated: Jun 14, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
Addressing immortal time bias in precision medicine: Practical guidance and methods development
Deirdre Weymann1,2, Emanuel Krebs1, Dean A Regier1,3
1Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.
Health Services Research
|September 3, 2024
Summary
Multiple imputation (MI) offers advantages for adjusting immortal time bias in precision medicine studies. This method minimizes data loss and better quantifies uncertainty, improving real-world evidence generation.
Area of Science:
- Biostatistics
- Epidemiology
- Health Services Research
Background:
- Immortal time bias is a significant challenge in observational studies, particularly in precision medicine evaluations.
- Existing adjustment methods have theoretical limitations that can impact the validity of real-world evidence.
Purpose of the Study:
- To compare the strengths and limitations of common immortal time adjustment methods.
- To propose and evaluate a novel approach using multiple imputation (MI) for immortal time bias adjustment.
- To provide practical guidance for implementing MI in precision medicine research.
Main Methods:
- Comparative analysis of landmark analysis, time-distribution matching, and time-dependent analysis against the proposed MI method.
- Development of practical guidance for MI application, including imputation method selection, model specification, and analysis pooling.
- A real-world case study using matched cohort design to evaluate survival benefits of whole-genome and transcriptome analysis in advanced cancers, applying both time-distribution matching and MI.
- Bootstrap simulations to assess imputation sensitivity to missing data and sample size.
Main Results:
- Multiple imputation (MI) theoretically offers advantages over other methods by minimizing information loss and better characterizing statistical uncertainty.
- MI explicitly accounts for patient characteristics influencing immortal time distributions, reducing potential bias.
- In the case study, MI and time-distribution matching yielded similar survival analysis results, though MI produced higher standard errors.
- Imputed immortal time remained stable across simulation scenarios.
Conclusions:
- Robust immortal time adjustment methods are crucial for generating unbiased, decision-grade real-world evidence in precision medicine.
- Multiple imputation (MI) presents a promising and effective solution for addressing immortal time bias in these evaluations.
Related Concept Videos
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Next-generation Sequencing
88.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.5K
Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Sanger Sequencing
753.9K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
753.9K

